This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2013 May;12(5):329-32.

doi: 10.1038/nrd4009.

Maturing antibody-drug conjugate pipeline hits 30

PMID: 23629491
DOI: 10.1038/nrd4009

Maturing antibody-drug conjugate pipeline hits 30

Asher Mullard. Nat Rev Drug Discov. 2013 May.

. 2013 May;12(5):329-32.

doi: 10.1038/nrd4009.

Author

PMID: 23629491
DOI: 10.1038/nrd4009

Erratum in

Nat Rev Drug Discov. 2013 Jun;12(6):483

No abstract available

PubMed Disclaimer

Similar articles

The changing landscape of cancer drug discovery: a challenge to the medicinal chemist of tomorrow.
Pors K, Goldberg FW, Leamon CP, Rigby AC, Snyder SA, Falconer RA. Pors K, et al. Drug Discov Today. 2009 Nov;14(21-22):1045-50. doi: 10.1016/j.drudis.2009.07.004. Epub 2009 Jul 26. Drug Discov Today. 2009. PMID: 19638319 Review.
Antibody-Drug Conjugates.
Peng L, Chen X. Peng L, et al. Bioconjug Chem. 2015 Nov 18;26(11):2169. doi: 10.1021/acs.bioconjchem.5b00515. Bioconjug Chem. 2015. PMID: 26577284 Free PMC article. No abstract available.
Trends in immunoconjugate and ligand-receptor based targeting development for cancer therapy.
Brumlik MJ, Daniel BJ, Waehler R, Curiel DT, Giles FJ, Curiel TJ. Brumlik MJ, et al. Expert Opin Drug Deliv. 2008 Jan;5(1):87-103. doi: 10.1517/17425247.5.1.87. Expert Opin Drug Deliv. 2008. PMID: 18095930 Review.
Challenges in the development and manufacturing of antibody-drug conjugates.
Ducry L. Ducry L. Methods Mol Biol. 2012;899:489-97. doi: 10.1007/978-1-61779-921-1_29. Methods Mol Biol. 2012. PMID: 22735971
New drug development.
Cheson BD. Cheson BD. Clin Adv Hematol Oncol. 2009 Sep;7(9):556. Clin Adv Hematol Oncol. 2009. PMID: 20020666 No abstract available.

See all similar articles

Cited by

High throughput cytotoxicity screening of anti-HER2 immunotoxins conjugated with antibody fragments from phage-displayed synthetic antibody libraries.
Hou SC, Chen HS, Lin HW, Chao WT, Chen YS, Fu CY, Yu CM, Huang KF, Wang AH, Yang AS. Hou SC, et al. Sci Rep. 2016 Aug 23;6:31878. doi: 10.1038/srep31878. Sci Rep. 2016. PMID: 27550798 Free PMC article.
Application of Pharmacokinetic-Pharmacodynamic Modeling and Simulation for Antibody-Drug Conjugate Development.
Singh AP, Shin YG, Shah DK. Singh AP, et al. Pharm Res. 2015 Nov;32(11):3508-25. doi: 10.1007/s11095-015-1626-1. Epub 2015 Feb 11. Pharm Res. 2015. PMID: 25666843 Review.
Antibody Drug Conjugates: Nonclinical Safety Considerations.
Hinrichs MJ, Dixit R. Hinrichs MJ, et al. AAPS J. 2015 Sep;17(5):1055-64. doi: 10.1208/s12248-015-9790-0. Epub 2015 May 30. AAPS J. 2015. PMID: 26024656 Free PMC article. Review.
Evolving Strategies for Target Selection for Antibody-Drug Conjugates.
Damelin M, Zhong W, Myers J, Sapra P. Damelin M, et al. Pharm Res. 2015 Nov;32(11):3494-507. doi: 10.1007/s11095-015-1624-3. Epub 2015 Jan 15. Pharm Res. 2015. PMID: 25585957
Antibody-drug conjugates: Recent advances in linker chemistry.
Su Z, Xiao D, Xie F, Liu L, Wang Y, Fan S, Zhou X, Li S. Su Z, et al. Acta Pharm Sin B. 2021 Dec;11(12):3889-3907. doi: 10.1016/j.apsb.2021.03.042. Epub 2021 Apr 6. Acta Pharm Sin B. 2021. PMID: 35024314 Free PMC article. Review.

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Other Literature Sources
- The Lens - Patent Citations Database
- scite Smart Citations